Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441773![]() (US10640533, Identification number CX13-103 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 0.920 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441775![]() (US10640533, Identification number CX13-105 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 0.970 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441773![]() (US10640533, Identification number CX13-103 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.09 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441775![]() (US10640533, Identification number CX13-105 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.34 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441779![]() (US10640533, Identification number CX13-133 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.58 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441789![]() (US10640533, Identification number CX13-608 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.73 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441789![]() (US10640533, Identification number CX13-608 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.26 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441784![]() (US10640533, Identification number CX13-600 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.28 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441779![]() (US10640533, Identification number CX13-133 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.65 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441776![]() (US10640533, Identification number CX13-107 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.74 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441776![]() (US10640533, Identification number CX13-107 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 5.10 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441788![]() (US10640533, Identification number CX13-606 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441780![]() (US10640533, Identification number CX13-135 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.56 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441787![]() (US10640533, Identification number CX13-605 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.81 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441784![]() (US10640533, Identification number CX13-600 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 7.41 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441790![]() (US10640533, Identification number CX13-705 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 9.75 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441786![]() (US10640533, Identification number CX13-603 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 11.1 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441787![]() (US10640533, Identification number CX13-605 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 12.2 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441781![]() (US10640533, Identification number CX13-137 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 13.5 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441786![]() (US10640533, Identification number CX13-603 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 14.2 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441790![]() (US10640533, Identification number CX13-705 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 15.3 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441785![]() (US10640533, Identification number CX13-601 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441780![]() (US10640533, Identification number CX13-135 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 28.1 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441785![]() (US10640533, Identification number CX13-601 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 31.7 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441774![]() (US10640533, Identification number CX13-104 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 33.3 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441774![]() (US10640533, Identification number CX13-104 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 33.6 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441788![]() (US10640533, Identification number CX13-606 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 59.3 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441781![]() (US10640533, Identification number CX13-137 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 60.4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441778![]() (US10640533, Identification number CX13-130 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 62.4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441783![]() (US10640533, Identification number CX13-501 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 113 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441782![]() (US10640533, Identification number CX13-500 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 121 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM50398607![]() (ONX 0912 | OPROZOMIB | US10640533, Identification ...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 124 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441782![]() (US10640533, Identification number CX13-500 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441788![]() (US10640533, Identification number CX13-606 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 186 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441778![]() (US10640533, Identification number CX13-130 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 248 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM50398607![]() (ONX 0912 | OPROZOMIB | US10640533, Identification ...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 256 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441788![]() (US10640533, Identification number CX13-606 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 297 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441783![]() (US10640533, Identification number CX13-501 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 392 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441779![]() (US10640533, Identification number CX13-133 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 443 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441779![]() (US10640533, Identification number CX13-133 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 455 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441789![]() (US10640533, Identification number CX13-608 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 490 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441777![]() (US10640533, Identification number CX13-109 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >500 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chymotrypsin-like protease CTRL-1 (Homo sapiens (Human)) | BDBM441777![]() (US10640533, Identification number CX13-109 | US106...) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >500 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441789![]() (US10640533, Identification number CX13-608 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 542 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441778![]() (US10640533, Identification number CX13-130 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441778![]() (US10640533, Identification number CX13-130 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441781![]() (US10640533, Identification number CX13-137 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 5.86E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441776![]() (US10640533, Identification number CX13-107 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441780![]() (US10640533, Identification number CX13-135 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441776![]() (US10640533, Identification number CX13-107 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 9.95E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441781![]() (US10640533, Identification number CX13-137 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.19E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441780![]() (US10640533, Identification number CX13-135 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.34E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441773![]() (US10640533, Identification number CX13-103 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.44E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441773![]() (US10640533, Identification number CX13-103 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.53E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441790![]() (US10640533, Identification number CX13-705 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.58E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441784![]() (US10640533, Identification number CX13-600 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.99E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441790![]() (US10640533, Identification number CX13-705 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441775![]() (US10640533, Identification number CX13-105 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441779![]() (US10640533, Identification number CX13-133 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441787![]() (US10640533, Identification number CX13-605 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441776![]() (US10640533, Identification number CX13-107 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441778![]() (US10640533, Identification number CX13-130 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441781![]() (US10640533, Identification number CX13-137 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441784![]() (US10640533, Identification number CX13-600 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM50398607![]() (ONX 0912 | OPROZOMIB | US10640533, Identification ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441783![]() (US10640533, Identification number CX13-501 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441786![]() (US10640533, Identification number CX13-603 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441774![]() (US10640533, Identification number CX13-104 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441782![]() (US10640533, Identification number CX13-500 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441784![]() (US10640533, Identification number CX13-600 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441787![]() (US10640533, Identification number CX13-605 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM50398607![]() (ONX 0912 | OPROZOMIB | US10640533, Identification ...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441777![]() (US10640533, Identification number CX13-109 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441782![]() (US10640533, Identification number CX13-500 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441785![]() (US10640533, Identification number CX13-601 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441786![]() (US10640533, Identification number CX13-603 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441774![]() (US10640533, Identification number CX13-104 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441775![]() (US10640533, Identification number CX13-105 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441785![]() (US10640533, Identification number CX13-601 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441786![]() (US10640533, Identification number CX13-603 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441774![]() (US10640533, Identification number CX13-104 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441780![]() (US10640533, Identification number CX13-135 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441788![]() (US10640533, Identification number CX13-606 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441773![]() (US10640533, Identification number CX13-103 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441776![]() (US10640533, Identification number CX13-107 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441781![]() (US10640533, Identification number CX13-137 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441782![]() (US10640533, Identification number CX13-500 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441784![]() (US10640533, Identification number CX13-600 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441773![]() (US10640533, Identification number CX13-103 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM50398607![]() (ONX 0912 | OPROZOMIB | US10640533, Identification ...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441775![]() (US10640533, Identification number CX13-105 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441787![]() (US10640533, Identification number CX13-605 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441789![]() (US10640533, Identification number CX13-608 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM50398607![]() (ONX 0912 | OPROZOMIB | US10640533, Identification ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441774![]() (US10640533, Identification number CX13-104 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441777![]() (US10640533, Identification number CX13-109 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441783![]() (US10640533, Identification number CX13-501 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441785![]() (US10640533, Identification number CX13-601 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441775![]() (US10640533, Identification number CX13-105 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441779![]() (US10640533, Identification number CX13-133 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441782![]() (US10640533, Identification number CX13-500 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441783![]() (US10640533, Identification number CX13-501 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441786![]() (US10640533, Identification number CX13-603 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441788![]() (US10640533, Identification number CX13-606 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441790![]() (US10640533, Identification number CX13-705 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441778![]() (US10640533, Identification number CX13-130 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441777![]() (US10640533, Identification number CX13-109 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441790![]() (US10640533, Identification number CX13-705 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441785![]() (US10640533, Identification number CX13-601 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441783![]() (US10640533, Identification number CX13-501 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transmembrane protease serine 11D (Homo sapiens (Human)) | BDBM441777![]() (US10640533, Identification number CX13-109 | US106...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441789![]() (US10640533, Identification number CX13-608 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441780![]() (US10640533, Identification number CX13-135 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteasome subunit beta type-1/beta type-5 (Homo sapiens (Human)) | BDBM441787![]() (US10640533, Identification number CX13-605 | US106...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CENTRAX INTERNATIONAL, INC. US Patent | Assay Description Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea... | US Patent US10640533 (2020) | |||||||||||
More data for this Ligand-Target Pair |